CD24 and diffuse large B-cell lymphoma: Notably, SN3 antibody treatment of DLBCL cell lines that expressed CD24, such as SU-DHL-10 and SU-DHL-6, did increase phagocytosis, albeit only up to 30% (Figure 4A).